Tag: bioequivalence generics

Cancer Medication Combinations: Bioequivalence Challenges for Generics

Generic cancer drugs save money, but combining them introduces serious bioequivalence risks. Learn why swapping one component in a combo therapy can change outcomes-and how regulators, hospitals, and patients are adapting.